Sotaglifozin
- CAS number
- 1018899-04-1
- Application
- Sotagliflozin is a dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus.
- Molecular weight
- 424.938 g/mol
- Molecular formula
- C21H25ClO5S
SOCOSUR OEL/OEB Risk Assessments are a quick and efficient way to obtain:
- Complete review of all relevant toxicological and medical databases as well as Material Safety Data Sheets and chemical books, in accordance with the regulations from National Institute for Occupational Safety and Health (NIOSH), Naumann and Safebridge
- A classification in four categories based on CLP Regulation and Naumann and Safebridge proposals
- A rational for NOAEL values selection
- Categorization for the specific work conditions
Benefits of such OEL/OEB Assessment
A 20 to 30 pages report signed by an European toxicological expert, optimized in case of Regulatory Body inspection, with all calculation details and all bibliographic references linked to these calculations, as well as all the development and results for the categorization of the product.